Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Secretion of high molecular weight (HMW) adiponectin is dependent on post-translational modification (PTM) of conserved lysines in the collagenous domain. The present study aims to characterize the enzymes responsible for the PTM of conserved lysines which leads to HMW adiponectin secretion, and to define its significance in relation to
obesity
. Collagen beta (1-
O
) galactosyltransferase 1 (
GLT25D1
) was knocked down in HEK cells modified for the stable expression of adiponectin (adiponectin expressing human embryonic kidney cells, Adipo-HEK) as well as in Simpson Golabi-Behmel-Syndrome (SGBS) adipocytes. Knockdown of
GLT25D1
caused a significant decrease in HMW adiponectin in Adipo-HEK cells with no change in total adiponectin. Knockdown in the SGBS cells caused an increase in lipid accumulation yet inhibited adipogenesis. Co-immunoprecipitation with adiponectin and mass spectrometry showed that adiponectin formed a protein complex with lysyl hydroxylase 3 (LH3) and
GLT25D1
. Transient overexpression of
GLT25D1
showed that the intracellular retention of LH3 was dependent on
GLT25D1
. To determine whether changes in
GLT25D1
were significant in
obesity
, mice were fed a standard chow or high-fat diet (HFD) for 5 weeks.
GLT25D1
was significantly decreased in mice fed HFD which coincided with a decrease in HMW adiponectin. We conclude that
GLT25D1
regulates HMW adiponectin secretion and lipid accumulation, consistent with changes in mice after high-fat feeding. These results suggest a novel function of
GLT25D1
leading to decreased HMW adiponectin secretion in early
obesity
.
...
PMID:Collagen beta (1-
O
) galactosyltransferase 1 (GLT25D1) is required for the secretion of high molecular weight adiponectin and affects lipid accumulation. 2842 30